Insider Selling: Doximity (NYSE:DOCS) Insider Sells $59,502.93 in Stock

Doximity, Inc. (NYSE:DOCS) insider Siddharth Sitaram sold 2,309 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $25.77, for a total transaction of $59,502.93. Following the completion of the transaction, the insider directly owned 89,396 shares in the company, valued at $2,303,734.92. This represents a 2.52% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Siddharth Sitaram also recently made the following trade(s):

• On Friday, April 10th, Siddharth Sitaram sold 2,427 shares of Doximity stock. The stock was sold at an average price of $21.09, for a total transaction of $51,185.43.
• On Tuesday, March 10th, Siddharth Sitaram sold 2,319 shares of Doximity stock. The stock was sold at an average price of $25.37, for a total transaction of $58,833.03.

Doximity Stock Up 5.1%

DOCS stock opened at $18.93 on Friday. The stock has a market cap of $3.50 billion, a P/E ratio of 19.12, a PEG ratio of 1.28 and a beta of 1.36. Doximity, Inc. has a 12 month low of $17.15 and a 12 month high of $76.51. The business has a 50-day moving average of $23.94.

Doximity declared that its board has approved a share repurchase plan on Thursday, February 5th that allows the company to buyback $500.00 million in outstanding shares. This buyback authorization allows the company to buy up to 8% of its shares through open market purchases. Shares buyback plans are often a sign that the company’s board believes its stock is undervalued.

Key Headlines Impacting Doximity

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Doximity said revenue still grew year over year, and its earnings call highlighted strong engagement from AI tool adoption, suggesting the platform is gaining traction with physicians. Doximity Stock Falls on Q4 Earnings Miss, Revenues Beat, Margins Down
• Positive Sentiment: Doximity announced a partnership with Aledade to bring clinical AI tools into value-based care workflows, which could support longer-term adoption and monetization. DOCS Teams Up With Aledade to Bring Clinical AI to Value-Based Care
• Neutral Sentiment: Several articles noted the stock has become technically oversold after a sharp selloff, which could set up a bounce if sentiment improves. Down 25.7% in 4 Weeks, Here’s Why Doximity (DOCS) Looks Ripe for a Turnaround
• Negative Sentiment: Doximity missed quarterly earnings estimates and issued fiscal 2027 revenue guidance below Wall Street expectations, raising concerns that growth is slowing. Doximity, Inc. (DOCS) Q4 2026 Earnings Call Transcript
• Negative Sentiment: Analysts turned more cautious, with multiple firms cutting price targets or downgrading the stock, including Baird, Wells Fargo, BTIG, JPMorgan, Mizuho, BMO, Needham and Truist. DOCS vs. HIMS: Which Stock Is the Better Value Option?
• Negative Sentiment: Investor caution also increased after insider selling was disclosed, even though it was tied to a pre-arranged 10b5-1 plan and tax withholding. Doximity (NYSE:DOCS) Insider Siddharth Sitaram Sells 2,309 Shares

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of DOCS. Root Financial Partners LLC purchased a new position in shares of Doximity in the 3rd quarter worth approximately $30,000. Whittier Trust Co. of Nevada Inc. grew its position in shares of Doximity by 59.5% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 480 shares of the company’s stock worth $35,000 after buying an additional 179 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its position in shares of Doximity by 99.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 796 shares of the company’s stock worth $35,000 after buying an additional 397 shares during the last quarter. Toth Financial Advisory Corp grew its position in shares of Doximity by 100.0% in the 4th quarter. Toth Financial Advisory Corp now owns 1,000 shares of the company’s stock worth $44,000 after buying an additional 500 shares during the last quarter. Finally, Atlantic Union Bankshares Corp grew its position in shares of Doximity by 136.9% in the 3rd quarter. Atlantic Union Bankshares Corp now owns 616 shares of the company’s stock worth $45,000 after buying an additional 356 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on DOCS shares. Morgan Stanley cut their target price on shares of Doximity from $49.00 to $35.00 and set an “overweight” rating on the stock in a research report on Thursday. KeyCorp downgraded shares of Doximity from an “overweight” rating to a “sector weight” rating in a research report on Thursday. Jefferies Financial Group downgraded shares of Doximity from a “buy” rating to a “hold” rating and cut their target price for the company from $51.00 to $19.00 in a research report on Thursday. Needham & Company LLC cut their target price on shares of Doximity from $55.00 to $27.00 and set a “buy” rating on the stock in a research report on Thursday. Finally, Zacks Research raised shares of Doximity from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 21st. Two investment analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and fourteen have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $30.62.

About Doximity

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.